These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38896301)
1. Development of an HSV-1 production process involving serum-reduced culturing and bead-to-bead transfer. Wang H; Hu X; Zhang M; Yang L; Xu Y; Gu X; Jiang J; Hu W Appl Microbiol Biotechnol; 2024 Jun; 108(1):383. PubMed ID: 38896301 [TBL] [Abstract][Full Text] [Related]
2. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells. Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017 [TBL] [Abstract][Full Text] [Related]
3. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Rourou S; van der Ark A; van der Velden T; Kallel H Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281 [TBL] [Abstract][Full Text] [Related]
4. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density. Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175 [TBL] [Abstract][Full Text] [Related]
5. Development, optimization, and scale-up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus-1. Shen CF; Burney E; Gilbert R; Elahi SM; Parato K; Loignon M Biotechnol J; 2024 Jan; 19(1):e2300244. PubMed ID: 37767876 [TBL] [Abstract][Full Text] [Related]
6. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Rourou S; Ben Zakkour M; Kallel H Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054 [TBL] [Abstract][Full Text] [Related]
7. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor. Arifin MA; Mel M; Abdul Karim MI; Ideris A J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497 [TBL] [Abstract][Full Text] [Related]
8. Facile bead-to-bead cell-transfer method for serial subculture and large-scale expansion of human mesenchymal stem cells in bioreactors. Chen S; Sato Y; Tada Y; Suzuki Y; Takahashi R; Okanojo M; Nakashima K Stem Cells Transl Med; 2021 Sep; 10(9):1329-1342. PubMed ID: 34008349 [TBL] [Abstract][Full Text] [Related]
9. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697 [TBL] [Abstract][Full Text] [Related]
10. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor. Toriniwa H; Komiya T Biologicals; 2007 Oct; 35(4):221-6. PubMed ID: 17400474 [TBL] [Abstract][Full Text] [Related]
11. Suspension-Vero cell cultures as a platform for viral vaccine production. Paillet C; Forno G; Kratje R; Etcheverrigaray M Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123 [TBL] [Abstract][Full Text] [Related]
12. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Genzel Y; Fischer M; Reichl U Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544 [TBL] [Abstract][Full Text] [Related]
13. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium. Mattos DA; Silva MV; Gaspar LP; Castilho LR Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117 [TBL] [Abstract][Full Text] [Related]
14. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale. Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818 [TBL] [Abstract][Full Text] [Related]
15. Upstream process optimization and micro- and macrocarrier screening for large-scale production of the oncolytic H-1 protoparvovirus. Wohlfarth D; Frehtman V; Müller M; Vogel M; Phan LMP; Brunecker A; Leuchs B Appl Microbiol Biotechnol; 2021 Dec; 105(24):9113-9124. PubMed ID: 34782922 [TBL] [Abstract][Full Text] [Related]
16. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Berry JM; Barnabé N; Coombs KM; Butler M Biotechnol Bioeng; 1999 Jan; 62(1):12-9. PubMed ID: 10099508 [TBL] [Abstract][Full Text] [Related]
17. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures. Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958 [TBL] [Abstract][Full Text] [Related]
18. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311 [TBL] [Abstract][Full Text] [Related]
19. Production of yellow fever virus in microcarrier-based Vero cell cultures. Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120 [TBL] [Abstract][Full Text] [Related]
20. Development of suspension adapted Vero cell culture process technology for production of viral vaccines. Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]